Verrica Pharmaceuticals Share Price (NASDAQ: VRCA)
$5.59
▲
0.04
(0.72%)
Last updated on
Check the interactive Verrica Pharmaceuticals Stock chart to analyse performance
Verrica Pharmaceuticals stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$5.45Today's High:$5.59
2.5%
Downside
Day's Volatility :2.5%
Upside
0.0%
- 52 Weeks Low:$3.8252 Weeks High:$24.90
31.74%
Downside
52 Weeks Volatility :84.67%
Upside
77.55%
Verrica Pharmaceuticals Stock Returns
Verrica Pharmaceuticals Inc Key Stats
Check Verrica Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Verrica Pharmaceuticals Stock including INR - Dollar returns
The Verrica Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Verrica Pharmaceuticals investment value today
Current value as on today
₹30,926
Returns
Returns from Verrica Pharmaceuticals Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Verrica Pharmaceuticals Stock
Global Institutional Holdings in Verrica Pharmaceuticals Inc
Name
Holdings %
Caligan Partners LP
9.72%
Armistice Capital, LLC
9.26%
BOOTHBAY FUND MANAGEMENT, LLC
3.04%
Vanguard Group Inc
2.55%
BlackRock Inc
1.33%
Geode Capital Management, LLC
1.10%
Analyst Recommendation on Verrica Pharmaceuticals Stock
Buy
91%Buy
8%Hold
0%Sell
Based on 12 Wall street analysts offering stock ratings for Verrica Pharmaceuticals(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Verrica Pharmaceuticals Share Price Target
What analysts predicted
Upside of 168.34%
Target:
$15.00
Current:
$5.59
Verrica Pharmaceuticals share price target is $15.00, a slight Upside of 168.34% compared to current price of $5.59 as per analysts' prediction.
Verrica Pharmaceuticals Stock Insights
Price Movement
In the last 1 year, VRCA stock has moved down by -76.6%Increasing Revenue
Revenue is up for the last 4 quarters, -1.78M → 12.70M (in $), with an average increase of 260.2% per quarterIncreasing Net Profit
Netprofit is up for the last 4 quarters, -22.86M → 204.0K (in $), with an average increase of 1661.0% per quarterVRCA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 146.5%VRCA vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 197.3%Price to Sales
ForVRCA every $1 of sales, investors are willing to pay $2.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Verrica Pharmaceuticals Technicals Summary
Sell
Neutral
Buy
Verrica Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.
Verrica Pharmaceuticals Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -2.3% | -13.92% | -74.72% | -85.87% | -93.75% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -0.65 | -15.47 | -0.52 | NA | -1.89 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $52.4M | -93.75% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Verrica Pharmaceuticals Inc
Key Management of Verrica Pharmaceuticals Inc
Important FAQs about investing in VRCA Stock from India :
What is Verrica Pharmaceuticals share price today?
Verrica Pharmaceuticals share price today is $5.59 as on at the close of the market. Verrica Pharmaceuticals share today touched a day high of $5.59 and a low of $5.45.
What is the 52 week high and 52 week low for Verrica Pharmaceuticals share?
Verrica Pharmaceuticals share touched a 52 week high of $24.90 and a 52 week low of $3.82. Verrica Pharmaceuticals stock price today i.e. is closed at $5.59, lower by 77.55% versus the 52 week high.
How to invest in Verrica Pharmaceuticals Stock (VRCA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Verrica Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Verrica Pharmaceuticals Shares that will get you 0.2683 shares as per Verrica Pharmaceuticals share price of $5.59 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Verrica Pharmaceuticals Stock (VRCA) from India?
Indian investors can start investing in Verrica Pharmaceuticals (VRCA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Verrica Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Verrica Pharmaceuticals share’s latest price of $5.59 as on August 30, 2025 at 1:29 am IST, you will get 1.7889 shares of Verrica Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Verrica Pharmaceuticals has given to Indian investors in the last 5 years?
Verrica Pharmaceuticals stock has given -93.75% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%